Crossmark

A novel molecular classification based on efferocytosis-related genes for predicting clinical outcome and treatment response in acute myeloid leukemia

Crossref DOI link: https://doi.org/10.1007/s00011-024-01938-w

Published Online: 2024-09-02

Published Print: 2024-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhong, Fangmin

Yao, Fangyi

Bai, Qin

Liu, Jing

Li, Xiaolin

Huang, Bo

Wang, Xiaozhong
Funding

Funding for this research was provided by:

Natural Science Foundation of Jiangxi Province (20232BAB216037, 20232BAB216050, 20224BAB216037, 20232BAB216037, 20232BAB216050, 20224BAB216037, 20232BAB216037, 20232BAB216050, 20224BAB216037)

National Natural Science Foundation of China (82160405, 82160038, 82260035, 82301578, 82160405, 82160038, 82260035, 82301578, 82160405, 82160038, 82260035, 82301578, 82160405, 82160038, 82260035, 82301578)

Incubation Program of the Second Affiliated Hospital of Nanchang University (2022YNFY12007)
License Information

Text and Data Mining valid from 2024-09-02

Version of Record valid from 2024-09-02
More Information

Article History

Received: 25 May 2024

Revised: 6 August 2024

Accepted: 21 August 2024

First Online: 2 September 2024

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below